Navigation Links
Pharmaceutical Cold Supply Chain and Green Logistics, a New Xtalks Life Sciences Webinar
Date:8/16/2013

Toronto, Canada (PRWEB) August 16, 2013

Sustainability efforts in the pharma and biotech industry have mainly focused on buildings, utilities, manufacturing and sourcing initiatives but the cold chain supply has remained almost untouched due to the risk associated with product loss during distribution.

The high value of the products and the complexity of the global supply chain usually deems the risk of losing product due to temperature excursions as high and what follows is an over-design of shipping containers. Over-designed shipping containers usually bring not only a higher logistics cost but also higher emissions and waste.

This webinar will focus on sustainability efforts that can be applied immediately to any cold chain supply and also discusses common misconceptions and organizational silos found in cold chain supply.

A live Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit: http://www.xtalks.com/pharmagreenlogistics.ashx .

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx .

Contact:

Zayeeta Dasgupta, M.Sc in Life Science and Business Management
1- (416) 977-6555 ext. 260

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
3. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
4. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
5. Questcor Pharmaceuticals to Present at the Oppenheimer Healthcare Conference on December 13, 2011
6. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
7. The respective roles of the public and private sectors in pharmaceutical innovation
8. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
9. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
10. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... BioEnterprise today announced that Northeast Ohio ... in growth funding during the past 13 years.  Funding ... – including the Ohio Third Frontier - and federal ... raised in the past five years. ... BioEnterprise Midwest Healthcare Growth Capital  Report.   ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 According to ... “Agricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 ... USD 15,300 million in 2012 and is expected to ... CAGR of 9.5% from 2013 to 2019. , ...
(Date:2/26/2015)... Feb. 26, 2015  Epic Sciences announced today that ... present at the 35th Annual Cowen and Company Health ... the MIT Room, 3rd Floor. The conference will be ... Mass. Epic is developing diagnostic tests of ... and proteomic changes that occur during the course of ...
(Date:2/26/2015)... 26, 2015 Caris Life Sciences® today ... 2015 Genitourinary Cancers Symposium in Orlando, ... of tumor profiling. Both studies utilized Caris Molecular ... to identify biomarkers that shed light on potential ... cell bladder cancer (SCBC). In ...
Breaking Biology Technology:More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 2More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 3More Than $2 Billion Invested in Northeast Ohio Bioscience Start-Up Companies Since 2002 4Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 2Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 3Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 4Tumor Profiling of Metastatic Prostate and Small Cell Bladder Cancers with Caris Molecular Intelligence Yields Insights into Novel and Conventional Therapeutic Options 5
... announces that a new market research report is ... Discovery Techniques and Applications – A Global Market ... `A more focused discovery process using proteins ... the development stage for quite some time now. ...
... Calif., Sept. 21 TOPICA Pharmaceuticals, Inc. a privately-held ... a sublicense and purchase option agreement with an undisclosed ... the skin in the Americas and Europe. By agreement, ... In conjunction with the sublicensing agreement, TOPICA Pharmaceuticals ...
... NEW YORK and JERUSALEM, Sept. 21 Chiasma, ... Chiasma,s Chairman & CEO, will present an overview of the ... Grand Hyatt, New York, New York, on Wednesday, September 22, ... conducting its second clinical trial of the investigational new drug ...
Cached Biology Technology:Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 2Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 3Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 4Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 5Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 6Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 7Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 8Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 9Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 10Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 11Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 12Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 13Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 14Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 15Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 16Reportlinker Adds Biomarkers: Discovery Techniques and Applications - A Global Market Overview 17TOPICA Pharmaceuticals Announces Sublicensing Agreement for Tinea Indication 2Chiasma to Present at the UBS Global Life Sciences Conference 2Chiasma to Present at the UBS Global Life Sciences Conference 3
(Date:2/18/2015)... 18, 2015  Cepheid (NASDAQ: CPHD ) today ... conferences, and invited investors to participate via webcast. , ... Tuesday, March 3, 2015 at 11.20 a.m. Eastern ... Orlando, FL Wednesday, March 4, 2015 at 10.25 ... the live webcasts for these events, please visit Cepheid,s website ...
(Date:2/12/2015)... , Feb. 12, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62/113114 for DISTRIBUTED METHOD AND ... The patent further establishes NXT-ID,s position in the ... property portfolio the ability for multiple devices to collaborate ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... role of sensors and associated instrumentation technologies has ... stringent and sophisticated, requiring innovative development of sensor ... achieve these market demands. Novel tools, techniques and ... will be smaller, have increased sensitivity, require specific ...
... January 21, 2010 The bubbles in your champagne that ... are exhibiting a behavior quite similar to the tiny bubbles found ... But while the champagne bubbles are likely to raise ... and affect the climate. "Bubbles are little packets of gases ...
... A new study published in CMAJ ( Canadian ... severity of H1N1 influenza has found that admissions to ... longer interval between symptom onset and treatment with antivirals ... of First Nations ethnicity were also found to be ...
Cached Biology News:Conference to discuss future of nanotechnology enabled sensors 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 2Bubble physicist counts bubbles in the ocean to answer questions about climate, sound, light 3Disease severity in H1N1 patients 2
lid holder -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD45RA TAC is designed to deplete human CD45RA from samples to isolate memory CD4+ or CD8+ T cells....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... integrated digital microscope and camera system that ... optical adjustment or software installation. Built on ... combines simplicity and advanced technology for users ... viewing of a macro image and a ...
Biology Products: